Overall (n = 440) | Pre-COVID-19 (n = 258) | Wuhan pandemic (n = 55) | Post-Wuhan (n = 32) | Beijing pandemic (n = 35) | Post-Beijing (n = 60) | P value | |
---|---|---|---|---|---|---|---|
Age (years), median [IQR] | 63 [56–71] | 62 [55–69] | 65 [57–73] | 63 [56–72] | 67 [56–77] | 65 [58–74] | .072 |
Age ≥ 80 years, n(%) | 45 (10.2) | 18 (7.0) | 5 (9.1) | 5 (15.6) | 5 (14.3) | 12 (20.0) | .043 |
Male, n(%) | 310 (70.5) | 179 (69.4) | 39 (70.9) | 22 (68.8) | 29 (82.9) | 41 (68.3) | .573 |
Transferred, n(%) | 49 (11.1) | 32 (12.4) | 5 (9.1) | 5 (15.6) | 2 (5.7) | 5 (8.3) | .559 |
Bridging MT, n(%) | 43 (9.8) | 22 (8.5) | 5 (9.1) | 0 (0.0) | 9 (25.7) | 7 (11.7) | .006 |
Onset-to-arrival time (min), median [IQR] | 114.50 [73.00–165.00] | 120.00 [70.75–169.25] | 100.00 [70.50–149.50] | 117.50 [73.25–138.75] | 110.00 [75.50–185.00] | 120.50 [77.25–164.75] | .556 |
Arrival-to-CT time (min), median [IQR] | 16.00 [10.00–24.00] | 15.00 [8.00–21.00] | 17.00 [11.00–22.75] | 16.00 [10.00–30.00] | 25.00 [16.00–33.00] | 20.00 [13.75–28.00] | < .001 |
CT-to-tPA (min), median [IQR] | 29.00 [21.00–51.25] | 29.00 [20.25–52.00] | 31.00 [21.50–52.00] | 35.00 [23.50–106.25] | 30.00 [23.50–45.00] | 26.50 [19.75–41.00] | .372 |
DNT time (min), median [IQR] | 45.00 [35.00–61.00] | 43.00 [33.00–58.00] | 49.00 [35.00–64.00] | 48.50 [39.75–70.50] | 55.00 [45.50–70.00] | 47.00 [38.00–60.50] | .016 |
DNT ≤ 60 min, n(%) | 325 (73.9) | 200 (77.5) | 38 (69.1) | 20 (62.5) | 22 (62.9) | 45 (75.0) | .146 |
Onset-to-tPA (min), median [IQR] | 167.50 [126.75-220.50] | 166.50 [125.25–218.00] | 155.00 [123.00–204.50] | 170.00 [132.25, 219.25] | 169.00 [132.50–244.00] | 174.50 [126.00–227.00] | .597 |
Pre-mRS score, n(%) | .155 | ||||||
0 | 291 (76.6) | 179 (75.2) | 39 (88.6) | 20 (74.1) | 19 (79.2) | 34 (72.3) | |
1 | 44 (11.6) | 29 (12.2) | 0 (0.0) | 3 (11.1) | 4 (16.7) | 8 (17.0) | |
2 | 21 (5.5) | 14 (5.9) | 2 (4.5) | 1 (3.7) | 0 (0.0) | 4 (8.5) | |
3 | 14 (3.7) | 7 (2.9) | 3 (6.8) | 2 (7.4) | 1 (4.2) | 1 (2.1) | |
4 | 9 (2.4) | 8 (3.4) | 0 (0.0) | 1 (3.7) | 0 (0.0) | 0 (0.0) | |
5 | 1 (0.3) | 1 (0.4) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | |
Admission NIHSS score, median [IQR] | 5 [3-11] | 5 [3-9] | 8 [4-12] | 6 [4-10] | 7 [5-14] | 9 [4-12] | < .001 |
NIHSS score ≤ 3, n (%) | 126 (28.6) | 91 (35.3) | 9 (16.4) | 8 (25.0) | 6 (17.1) | 12 (20.0) | .006 |
NIHSS score ≤ 5, n (%) | 227 (51.6) | 148 (57.4) | 25 (45.5) | 16 (50.0) | 15 (42.9) | 23 (38.3) | .048 |
NIHSS score after tPA injection, median [IQR] | 3 [1-7] | 3 [1–6] | 5 [2–10] | 3 [1–7] | 5 [2–14] | 3 [1–9] | .013 |
NIHSS score at 2 h after tPA injection, median [IQR] | 4 [1–7] | 2 [1–6] | 3 [2–5] | 4 [1–8] | 4 [3, 13] | 4 [1–11] | .411 |
NIHSS score at 24 h after tPA injection, median [IQR] | 3 [1–7] | 2 [1–5] | 3 [1–10] | 4 [0–6] | 6 [3–12] | 3 [1–9] | .275 |
NIHSS reduction at 24 h, (median [IQR]) | 2 [0–4] | 2 [0–4] | 3 [0–4] | 2 [0–3] | 2 [-1–6] | 2 [0–5] | .915 |
Hypertension, n(%) | 225 (51.1) | 138 (53.5) | 29 (52.7) | 18 (56.2) | 13 (37.1) | 27 (45.0) | .330 |
Atrial fibrillation, n(%) | 38 (8.6) | 25 (9.7) | 5 (9.1) | 1 (3.1) | 1 (2.9) | 6 (10.0) | .398 |
Diabetes, n(%) | 101 (23.0) | 62 (24.0) | 10 (18.2) | 11 (34.4) | 3 (8.6) | 15 (25.0) | .113 |
Hyperlipidemia, n(%) | 48 (10.9) | 34 (13.2) | 4 (7.3) | 4 (12.5) | 3 (8.6) | 3 (5.0) | .281 |
Prior stroke, n(%) | 85 (19.3) | 57 (22.1) | 8 (14.5) | 5 (15.6) | 5 (14.3) | 10 (16.7) | .512 |
History of antiplatelet therapy, n(%) | 60 (13.6) | 30 (11.6) | 6 (10.9) | 6 (18.8) | 6 (17.1) | 12 (20.0) | .389 |
History of statin, n(%) | 47 (10.7) | 26 (10.1) | 5 (9.1) | 6 (18.8) | 2 (5.7) | 8 (13.3) | .468 |
Smoking, n(%) | 215 (48.9) | 127 (49.2) | 27 (49.1) | 18 (56.2) | 14 (40.0) | 29 (48.3) | .769 |
Drinking, n(%) | 179 (40.7) | 108 (41.9) | 22 (40.0) | 16 (50.0) | 10 (28.6) | 23 (38.3) | .467 |
TOAST, n(%) | .008 | ||||||
Large-artery atherosclerosis | 293 (66.6) | 187 (72.5) | 29 (52.7) | 21 (65.6) | 21 (60.0) | 35 (58.3) | |
Cardioembolism | 58 (13.2) | 34 (13.2) | 11 (20.0) | 4 (12.5) | 2 (5.7) | 7 (11.7) | |
Small-vessel occlusion | 14 (3.2) | 10 (3.9) | 0 (0.0) | 1 (3.1) | 1 (2.9) | 2 (3.3) | |
Stroke of other determined etiology | 9 (2.0) | 4 (1.6) | 3 (5.5) | 1 (3.1) | 0 (0.0) | 1 (1.7) | |
Stroke of undetermined etiology | 66 (15.0) | 23 (8.9) | 12 (21.8) | 5 (15.6) | 11 (31.4) | 15 (25.0) | |
Admission SBP (mmHg), median [IQR] | 150 [136–166] | 151 [137–166] | 151 [130–160] | 156 [141–166] | 145 [130–165] | 145 [135–170] | .804 |
Admission DBP (mmHg), median [IQR] | 88 [78–96] | 88 [79–96] | 80 [74–93] | 92 [89–98] | 86 [79–95] | 83 [75–94] | .294 |